Rankings
▼
Calendar
VIR FY 2025 Earnings — Vir Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena
VIR
Vir Biotechnology, Inc.
$1B
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$69M
-7.6% YoY
Gross Profit
$57M
82.9% margin
Operating Income
-$468M
-682.7% margin
Net Income
-$438M
-638.9% margin
EPS (Diluted)
$-3.16
Cash Flow
Operating Cash Flow
-$392M
Free Cash Flow
-$397M
Stock-Based Comp.
$49M
Balance Sheet
Total Assets
$1.0B
Total Liabilities
$238M
Stockholders' Equity
$765M
Cash & Equivalents
$234M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$69M
$74M
-7.6%
Gross Profit
$57M
-$404M
+114.1%
Operating Income
-$468M
-$587M
+20.3%
Net Income
-$438M
-$522M
+16.1%
← Q4 2024
All Quarters
Q1 2025 →